| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-15,177 | -13,533 | -11,096 | -14,591 | -5,930 | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation | ||||||
63 | 61 | 49 | 44 | 41 | ||
Amortization | ||||||
956 | 736 | 704 | 690 | 691 | ||
Fixed assets written off | ||||||
7 | 0 | - | - | - | ||
Fair value adjustment, warrants | ||||||
- | - | 0 | -2,329 | 386 | ||
Fair value adjustment, contingent consideration | ||||||
0 | -210 | -140 | 300 | 0 | ||
Stock-based compensation | ||||||
574 | 1,441 | 609 | 0 | - | ||
Restricted stock granted to employees/directors | ||||||
607 | 1,038 | 487 | 603 | 0 | ||
Common stock granted to consultants | ||||||
210 | 360 | 381 | 0 | - | ||
Warrants issued to consultants | ||||||
- | - | 538 | 55 | - | ||
Warrants issued to placement agents | ||||||
- | - | - | - | 218 | ||
Warrants issued for lockup provisions | ||||||
- | - | - | 2,741 | 0 | ||
Interest expense settled with issuances of common stock | ||||||
- | - | - | - | 33 | ||
Accrued interest on convertible debt | ||||||
112 | 0 | 104 | 1,160 | 749 | ||
Convertible debt beneficial conversion feature | ||||||
- | - | -395 | -1,144 | 0 | ||
Accreted interest on debt discount - warrants | ||||||
313 | 97 | 280 | 883 | 812 | ||
Warrant modification | ||||||
0 | 428 | - | - | - | ||
Common stock issued for convertible debt extension | ||||||
- | - | 90 | 0 | - | ||
Warrant modification | ||||||
- | - | 397 | 0 | - | ||
Changes in assets and liabilities, net of effects of acquisition: | ||||||
Other receivables | ||||||
-749 | -2,187 | 3 | 132 | -638 | ||
Prepaid expenses | ||||||
-85 | -243 | -43 | -229 | 0 | ||
Right of use assets | ||||||
-82 | 0 | - | - | - | ||
Deposits | ||||||
3 | -15 | 5 | -9 | -6 | ||
Accounts payable and accrued expenses | ||||||
-420 | 741 | -233 | 805 | 251 | ||
Interest payable | ||||||
0 | -7 | 0 | 6 | -7 | ||
Other liabilities | ||||||
-366 | 0 | - | - | - | ||
Net cash used in operating activities | ||||||
-14,033 | -10,869 | -7,184 | -4,534 | -4,170 | ||
Cash flows from investing activities: | ||||||
Purchase of property and equipment | ||||||
24 | 55 | 32 | - | - | ||
Purchase of property and equipment | ||||||
0 | 250 | 0 | 12 | 24 | ||
Net cash used in investing activities | ||||||
-24 | -305 | -32 | -12 | -24 | ||
Cash flows from financing activities: | ||||||
Net proceeds from issuances of common stock and warrants | ||||||
9,476 | 11,902 | - | - | - | ||
Proceeds from sale of stock - IPO | ||||||
- | - | - | 5,280 | 0 | ||
Payments of offering costs - IPO | ||||||
- | - | - | 1,420 | 340 | ||
Proceeds issuances of common stock, net | ||||||
- | - | - | 0 | - | ||
Issuances of convertible promissory notes | ||||||
- | - | - | - | 445 | ||
Repayments of convertible promissory notes | ||||||
- | - | - | - | 701 | ||
Proceeds issuances of convertible debt, net | ||||||
4,967 | 0 | 1,000 | 2,094 | 5,395 | ||
Received from stockholder in relation to warrant modification | ||||||
61 | 0 | - | - | - | ||
Repayments of convertible debt | ||||||
1,550 | 286 | 0 | 362 | 117 | ||
Net proceeds from common stock issued for warrant exercises | ||||||
- | - | 0 | - | - | ||
Common stock issued from public offering, Amount | ||||||
- | - | 5,009 | - | - | ||
Proceeds of notes payable | ||||||
498 | 286 | 296 | 232 | 0 | ||
Repayments of notes payable | ||||||
309 | 190 | 292 | 76 | 0 | ||
Net cash provided by financing activities | ||||||
13,144 | 11,712 | 6,013 | 5,746 | 4,680 | ||
Increase (decrease) in cash | ||||||
-921 | 537 | -1,203 | 1,199 | 486 | ||
Effect of exchange rate changes on cash | ||||||
-25 | 3 | 3 | -7 | 0 | ||
Supplemental disclosures of cash flow information: | ||||||
Cash paid for interest | ||||||
8 | 4 | 4 | 1 | 0 | ||
Cash paid for taxes | ||||||
- | - | 0 | 0 | 0 | ||
Non-cash investing and financing activities: | ||||||
Issuance of 5,242 shares of common stock as payment of interest on convertible promissory notes | ||||||
- | - | - | - | 33 | ||
Conversion of preferred shares into common shares by Protea | ||||||
- | - | - | 3,479 | 1,421 | ||
Conversion of convertible promissory notes into convertible debt | ||||||
- | - | - | 135 | 0 | ||
Conversion of convertible debt into common stock | ||||||
- | - | 717 | 9,828 | 0 | ||
Common stock issued Mayoly for patents, Amount | ||||||
0 | 1,300 | 0 | - | - | ||
Common stock issued to Mayloy for patents, amount | ||||||
1,740 | 0 | - | - | - | ||
Warrant modification related to convertible debt issuance | ||||||
325 | 0 | - | - | - | ||
Warrant liability reclassified into additional paid in capital at IPO | ||||||
- | - | - | 3,670 | 0 | ||